Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Eric Achtmann
AddedMar 31, 2024
UpdatedMay 31, 2026
Eric Achtmann

Eric Achtmann

Board Member, Celdara Medical

CrunchbaseLinkedIn

Eric Achtmann's Career

Celdara Medical
Celdara Medical

Lebanon, TN, US

Board Member· Board
VeriTX
VeriTX

East Aurora, NY, US

Board Member· Board
Target Arm
Target Arm

Ridgefield, CT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Eric Achtmann's Career

Celdara Medical
Celdara Medical
Seed$1.7M282008Lebanon, TN, US
Board Member· Board

Leadership at Celdara Medical

Jake RederJake RederFounder & CEO

Similar to Celdara Medical

Blossom InnovationsBlossom InnovationsBoston, MA, USMedical Devicesest. 2011Blossom InnovationsBoston, MA, US · est. 2011

Blossom Innovations: Transforming early-stage scientific ideas into novel medical technologies.

Series A · $9M14
Curie.BioCurie.BioBoston, MA, USDrug Developmentest. 2022Curie.BioBoston, MA, US · est. 2022

Curie.Bio: A seed-stage venture firm specializing in drug-focused services for founders.

Series B26
Proa MedicalProa MedicalRedondo Beach, CA, USMedical Devicesest. 2010Proa MedicalRedondo Beach, CA, US · est. 2010

Proa Medical: High-throughput developer and distributor of innovative medical devices.

Pre-Seed · $2.8M2
Inception IBDInception IBDSan Diego, CA, USAnalyticsest. 2014Inception IBDSan Diego, CA, US · est. 2014

Translating academic IBD discoveries.

Series A · $14.1M30
VeriTX
VeriTX

East Aurora, NY, US

Board Member· Board
Target Arm
Target Arm
Seed$420k22017Ridgefield, CT, US
Board Member· Board

Leadership at Target Arm

Ryan BighamRyan BighamCo-Founder
Jeffrey McChesneyJeffrey McChesneyBoard Member

Similar to Target Arm

ArmIt CompanyArmIt CompanyNorwood, NJ, USIoT Servicesest. 2014ArmIt CompanyNorwood, NJ, US · est. 2014

ArmIt: A secure, global IoT service provider, powering connectivity and data management for all connected 'things'.

Seed · $260k8
Target EagleTarget EagleIrvine, CA, USMobile App, Softwareest. 2023Target EagleIrvine, CA, US · est. 2023

Utilizing A.I. to enhance services for the airsoft community.

Pre-Seed · $250k5
AirgilityAirgilityCollege Park, MD, USDronesest. 2017AirgilityCollege Park, MD, US · est. 2017

Airgility: Expert designer and manufacturer of unmanned aerial systems.

Angel · $225k15
Inova DroneInova DroneSan Diego, CA, USDrones, UAVest. 2014Inova DroneSan Diego, CA, US · est. 2014

Inova Drone: Designing, manufacturing, and servicing high-performance UAVs for critical applications.

Seed · $120k30

Eric Achtmann's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Eric Achtmann

Tony PantusoTony PantusoCo-Founder · Neocarta VenturesBader A. AL-SumaitBader A. AL-SumaitCo-Founder · Global Investment HouseScott PowersScott PowersBoard Member · Sun Life FinancialAlessandro RivettiAlessandro RivettiCo-Founder · R-301 CapitalCraig TallCraig TallBoard Member · Beat BiotherapeuticsRich RedelfsRich RedelfsBoard Member · Transphorm